glp-1 receptor agonist dry eye Frontiers GLP-1 Receptor Agonists and the
Description
In a systematic review of 55 double-blinded, placebo-controlled randomized clinical trials, GLP-1RA treatment was associated with an increased risk of cholelithiasis compared with placebo (RR 1.46, 95% CI 1.091.97) but not cholecystitis, cholangitis, or pancreatitis (63)
Focus on nutrient-dense foods that provide essential vitamins, minerals, and macronutrients in smaller volumes

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study

Note that all prescriptions are at the discretion of your healthcare provider.

If you know you want a plan that covers GLP-1 drugs like Wegovy and Ozempic, doing this research in advance is your best bet

Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity
